Decreased lymphocyte proliferation in response to mitogen
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Severe Combined Immunodeficiency
|
0.620 |
Biomarker
|
disease |
CLINGEN |
Structural analysis of low TCR-CD3 complex expression in T cells of an immunodeficient patient.
|
1370449 |
1992 |
Diabetes Mellitus, Insulin-Dependent
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
While no association was found between this locus and type I diabetes, a significant difference in the frequency of the CD3 epsilon 8-kb allele was found between male and female patients (0.268 versus 0.430; P less than 0.0025, Pc = 0.02) and between female patients and healthy female controls (0.430 versus 0.267; P less than 0.015).
|
1671006 |
1991 |
Autoimmune Diseases
|
0.030 |
Biomarker
|
group |
BEFREE |
A diallelic RFLP of the CD3-epsilon chain of the clonotypic T-lymphocyte receptor is not associated with certain autoimmune diseases.
|
1671848 |
1991 |
Lymphoid depletion
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Within an assessed lymphoid depletion, the patient's tissues showed a normal expression of several TCR epitopes (those associated to CD3 epsilon, CD3 delta and the clonotypic -Ti- alpha and beta chains).
|
1709425 |
1991 |
Severe Combined Immunodeficiency
|
0.620 |
Biomarker
|
disease |
CLINGEN |
Pairwise, cooperative and inhibitory interactions describe the assembly and probable structure of the T-cell antigen receptor.
|
1828760 |
1991 |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Transcripts of the CD3-delta and CD3-epsilon genes were present in all CD3- and CD3+ T-ALL tested, including prothymocytic T-ALL.
|
3100631 |
1987 |
T-lymphocyte immunodeficiency
|
0.010 |
Biomarker
|
disease |
BEFREE |
The T cell immunodeficiency was caused by either the human or the murine CD3 epsilon protein.
|
7794823 |
1995 |
Severe Combined Immunodeficiency
|
0.620 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene.
|
7937778 |
1994 |
Severe Combined Immunodeficiency
|
0.620 |
Biomarker
|
disease |
CLINGEN |
A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene.
|
7937778 |
1994 |
IMMUNODEFICIENCY 18
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene.
|
7937778 |
1994 |
Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
Immunocytometry studies (dual staining for CD3 epsilon and TfR) demonstrated that autologous T cells from the peripheral blood but not from the tumor expressed TfR following stimulation with IL2, anti-CD3 or PHA.
|
8050820 |
1994 |
Severe Combined Immunodeficiency
|
0.620 |
Biomarker
|
disease |
CLINGEN |
Independent mutations of the human CD3-epsilon gene resulting in a T cell receptor/CD3 complex immunodeficiency.
|
8490660 |
1993 |
IMMUNODEFICIENCY 18
|
0.600 |
GeneticVariation
|
disease |
CLINVAR |
Independent mutations of the human CD3-epsilon gene resulting in a T cell receptor/CD3 complex immunodeficiency.
|
8490660 |
1993 |
Immunologic Deficiency Syndromes
|
0.410 |
Biomarker
|
group |
CTD_human |
Independent mutations of the human CD3-epsilon gene resulting in a T cell receptor/CD3 complex immunodeficiency.
|
8490660 |
1993 |
Antibody Deficiency Syndrome
|
0.300 |
Biomarker
|
disease |
CTD_human |
Independent mutations of the human CD3-epsilon gene resulting in a T cell receptor/CD3 complex immunodeficiency.
|
8490660 |
1993 |
Lymphomatoid Granulomatosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Phenotypically, the lymphoid cells in the AIL-II patients were positive for CD3 epsilon; two of these showed a positive reaction to CD2, CD7, and CD8, but lacked natural killer-associated (NKa) antigens CD16, CD56, and CD57.
|
8522304 |
1995 |
Ovarian Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The data indicate that alterations in expression of CD3-zeta and CD3-epsilon chains in T cells coincubated with OvCA are related to tumor-induced apoptosis, as the addition of pan-caspase inhibitors, DEVD-cho or YVAD-cho, prevents both the in vitro induction of T cell death by OvCA cells and the changes in the level of expression of CD3-zeta and CD3-epsilon chains.
|
9616229 |
1998 |
Malignant neoplasm of ovary
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The data indicate that alterations in expression of CD3-zeta and CD3-epsilon chains in T cells coincubated with OvCA are related to tumor-induced apoptosis, as the addition of pan-caspase inhibitors, DEVD-cho or YVAD-cho, prevents both the in vitro induction of T cell death by OvCA cells and the changes in the level of expression of CD3-zeta and CD3-epsilon chains.
|
9616229 |
1998 |
Carcinoma, Ovarian Epithelial
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The data indicate that alterations in expression of CD3-zeta and CD3-epsilon chains in T cells coincubated with OvCA are related to tumor-induced apoptosis, as the addition of pan-caspase inhibitors, DEVD-cho or YVAD-cho, prevents both the in vitro induction of T cell death by OvCA cells and the changes in the level of expression of CD3-zeta and CD3-epsilon chains.
|
9616229 |
1998 |
Graft-vs-Host Disease
|
0.020 |
Biomarker
|
disease |
BEFREE |
Anti-CD3 epsilon F(ab')2 prevents graft-versus-host disease by selectively depleting donor T cells activated by recipient alloantigens.
|
11313428 |
2001 |
Rheumatoid Arthritis
|
0.300 |
Biomarker
|
disease |
CTD_human |
From transcriptome to proteome: differentially expressed proteins identified in synovial tissue of patients suffering from rheumatoid arthritis and osteoarthritis by an initial screen with a panel of 791 antibodies.
|
12833524 |
2003 |
Celiac Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
Refractory celiac sprue, a low-grade intraepithelial lymphoma characterized by expansion of clonal intraepithelial lymphocytes with intracellular CD3 epsilon but no surface CD3-T-cell receptor complexes, can be an intermediary step between celiac disease and overt T-cell lymphoma.
|
12851869 |
2003 |
T-Cell Lymphoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Refractory celiac sprue, a low-grade intraepithelial lymphoma characterized by expansion of clonal intraepithelial lymphocytes with intracellular CD3 epsilon but no surface CD3-T-cell receptor complexes, can be an intermediary step between celiac disease and overt T-cell lymphoma.
|
12851869 |
2003 |
Severe Combined Immunodeficiency
|
0.620 |
Biomarker
|
disease |
CLINGEN |
Severe combined immunodeficiency caused by deficiency in either the delta or the epsilon subunit of CD3.
|
15546002 |
2004 |